ProKidney Statistics

Total Valuation

ProKidney has a market cap or net worth of $703.95 million. The enterprise value is $436.46 million.

Market Cap	703.95M
Enterprise Value	436.46M

Important Dates

The last earnings date was Monday, November 10, 2025, before market open.

Earnings Date	Nov 10, 2025
Ex-Dividend Date	n/a

Share Statistics

ProKidney has 300.83 million shares outstanding. The number of shares has increased by 60.61% in one year.

Current Share Class	141.55M
Shares Outstanding	300.83M
Shares Change (YoY)	+60.61%
Shares Change (QoQ)	+3.26%
Owned by Insiders (%)	17.81%
Owned by Institutions (%)	15.62%
Float	93.27M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	946.17
Forward PS	n/a
PB Ratio	2.21
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	586.64
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.32, with a Debt / Equity ratio of 0.01.

Current Ratio	10.32
Quick Ratio	9.39
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-34,177.80

Financial Efficiency

Return on equity (ROE) is -41.81% and return on invested capital (ROIC) is -27.65%.

Return on Equity (ROE)	-41.81%
Return on Assets (ROA)	-25.85%
Return on Invested Capital (ROIC)	-27.65%
Return on Capital Employed (ROCE)	-52.98%
Revenue Per Employee	$3,647
Profits Per Employee	-$348,201
Employee Count	204
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

In the past 12 months, ProKidney has paid $3.70 million in taxes.

Income Tax	3.70M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +16.42% in the last 52 weeks. The beta is 1.82, so ProKidney's price volatility has been higher than the market average.

Beta (5Y)	1.82
52-Week Price Change	+16.42%
50-Day Moving Average	2.73
200-Day Moving Average	1.88
Relative Strength Index (RSI)	45.52
Average Volume (20 Days)	1,405,101

Short Selling Information

The latest short interest is 13.96 million, so 4.64% of the outstanding shares have been sold short.

Short Interest	13.96M
Short Previous Month	12.29M
Short % of Shares Out	4.64%
Short % of Float	14.97%
Short Ratio (days to cover)	8.70

Income Statement

In the last 12 months, ProKidney had revenue of $744,000 and -$71.03 million in losses. Loss per share was -$0.54.

Revenue	744,000
Gross Profit	744,000
Operating Income	-170.89M
Pretax Income	-155.54M
Net Income	-71.03M
EBITDA	-164.58M
EBIT	-170.89M
Loss Per Share	-$0.54

Full Income Statement

Balance Sheet

The company has $271.73 million in cash and $4.24 million in debt, giving a net cash position of $267.49 million or $0.89 per share.

Cash & Cash Equivalents	271.73M
Total Debt	4.24M
Net Cash	267.49M
Net Cash Per Share	$0.89
Equity (Book Value)	318.34M
Book Value Per Share	-7.41
Working Capital	270.93M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$111.78 million and capital expenditures -$34.95 million, giving a free cash flow of -$146.73 million.

Operating Cash Flow	-111.78M
Capital Expenditures	-34.95M
Free Cash Flow	-146.73M
FCF Per Share	-$0.49

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-22,968.95%
Pretax Margin	-20,906.18%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ProKidney does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-60.61%
Shareholder Yield	-60.61%
Earnings Yield	-10.09%
FCF Yield	-20.84%

Dividend Details

Analyst Forecast

The average price target for ProKidney is $6.25, which is 167.09% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.25
Price Target Difference	167.09%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	381.00%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ProKidney has an Altman Z-Score of -1.73. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.73
Piotroski F-Score	n/a